Fortress Biotech to Ring Nasdaq Stock Market Closing Bell on December 21

NEXT STORY
Human Immunodeficiency Virus Type-1 (HIV-1) Industry Landscape Report 2021-2030 Featuring Insights Into Lenacapavir (GS-6207), GSK3640254 (GSK’254), and MK-8591A (Islatravir/doravirine; DOR/ISL)
PREV STORY
Predictive Oncology – Year-end Shareholder Update!
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform

author_avatar
NASDAQ Market News

AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD, in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency, at Biotech Showcase 2020 Conference (January 13) in San Francisco

author_avatar
NASDAQ Market News

eFFECTOR Appoints Barbara Klencke, M.D., to Board of Directors

author_avatar
NASDAQ Market News